Tetra Therapeutics is a clinical-stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression, and schizophrenia.

Education

Pharmaceutical

Tetra Therapeutics

Tetra Therapeutics' headquarters in Grand Rapids, MI, United States

Harvey Elgersma

Vladimir Skljarevski

Francie Kivel

Catherine D. Strader

James S. MacDonald

Edward M. Scolnick

The Scientific Team at Tetra Therapeutics focuses on the research and development of innovative medicinal therapies for neurological and psychiatric conditions such as Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression, and schizophrenia. The team collaborates to advance the clinical pipeline through rigorous scientific analysis, medicinal chemistry, and clinical trials.

Scientific Team

The Leadership Team at Tetra Therapeutics is responsible for strategic decision-making and guiding the company's vision in developing innovative treatments for neurological disorders. This team consists of key executives who oversee research and development, financial management, and organizational growth, ensuring that Tetra Therapeutics advances its clinical programs and achieves its goals in addressing unmet medical needs.

Tetra Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Tetra Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Related companies